Drugs / Tomoxetine
last change Dec 2020 re-read 9 days ago

Tomoxetine

Developed for
attention deficit-hyperactivity disorder
Investigated by
Xijing Hospital

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04065906 Jan → Dec 2019 attention deficit-hyperactivity disorder Xijing Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tomoxetine ClinicalTrials.gov intervention name — accepted as the source's own label NCT04065906 ↗